Last updated: February 6, 2023
Sponsor: Wageningen University and Research
Overall Status: Active - Recruiting
Phase
N/A
Condition
Stress
Treatment
N/AClinical Study ID
NCT05574530
NL75954.091.20
Ages 18-50 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Aged between 18-50 years old
- Participating in military field exercise
- BMI between 18.5 - 30 kg/m2
- Stable body weight (< 5 kg change) over the past 3-months;
Exclusion
Exclusion Criteria:
- Food allergies or other issues with foods that would preclude intake of the studyproducts
- History of gastro-intestinal surgery or gastro-intestinal complaints orgastrointestinal diseases (i.e., diarrhoea, Crohn's disease, ulcerative colitis,irritable bowel syndrome, diverticulosis, stomach or duodenal ulcers)
- Suffering from metabolic, neuro-psychiatric disease (i.e., diabetes, hepatitis, HIV,cancer, epilepsy, major depression, AD(H)D, schizophrenia, etc.)
- Taking medication related to gut diseases or stress
- Being severely immunocompromised (HIV positive, transplant patient, on antirejectionmedications, on a steroid for >30 days, or chemotherapy or radiotherapy within thelast year);
- Use of antibiotics within the previous 3 months
- Not willing to refrain from taking other supplements during the intervention period
- Pregnant, lactating or having a wish to become pregnant during the study
- History of drug and/or alcohol abuse at the time of enrolment
- Using doctor described drugs related to gut or neurological/psychiatric diseases
- Alcohol intake > 3 servings of alcoholic beverages per day
- Planned major changes in lifestyle (i.e. diet, dieting, exercise level, travelling)during the duration of the study
- Suffering from an eating disorder
- Vegetarian/vegan diet or other issues with foods that would preclude intake of thestudy products
- High fibre diet (i.e. >30 g) based on our fibre intake screening tool
- Receiving treatment involving experimental drugs. If the subject has been in a recentexperimental trial, these must have been completed not less than 60 days prior to thisstudy.
Study Design
Total Participants: 90
Study Start date:
October 12, 2022
Estimated Completion Date:
July 01, 2023
Study Description
Connect with a study center
Stichting Wageningen Research
Wageningen, Gelderland 6708 WG
NetherlandsActive - Recruiting


Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.